Abstract:Objective To develop an LC-MS/MS method for simultaneous determine the concentration of atorvastatin (AT) and its two active metabolites,ortho-hydmxyatorvastatin (o-AT) andpara-hydroxyatorvastatin (p-AT) in human plasma.Methods Deuterium-labeled compounds,o-AT-d5 and p-AT-d5were used as the internal standards.The analytes were extracted from human plasma through liquid liquid extraction method by using tert-butyl ether,after adding 5％ formic acid.The chromatographic separation was achieved on a CAPCELL PAK C18(2.0 mm× 100 mm,TYPE∶MG Ⅱ,5 μm) column with the mobile phase,consisted of a mixture of acetonitrile-5 mmol · L-1 ammonium acetate buffer-formic acid (46∶ 54∶ 0.143,v/v/v),in isocratic mode at a flow rate of 0.40 mL · min-1.Data acquisition was carried out in multiple reaction monitoring (MRM) mode.Analytes were detected on a tandem mass spectrometer,equipped with an electrospray ionization source that was operated in the positive mode,using the transitions of m/z 559.3→m/z 440.2 for atorvastatin,and m/z 575.3→m/z 440.2 for both ortho-and para-hydroxyatorvastatin.The selectivity,standard curve,precision and accuracy,extraction recoveries,matrix effect,carry over and stability were investigated.Results The linear range of atorvastatin was 0.05-100 ng · mL-1.The linear regression equation was y =4.35 × 10-2x + 3.43 × 10-4 (r =0.999 3) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The linear range of ortho-atorvastatin was 0.05-50 ng· mL-1.The linear regression equation was y =1.03 × 10-1x + 6.93 × 10-4 (r =0.998 7) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The linear range of para-atorvastatin was 0.05-5.0 ng · mL-1.The linear regression equation was y =5.35 × 10-1 x-2.26 × 10-3 (r =0.998 4) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The intra-day and inter-day relative standard deviations (RSD) of LLOQ,low,medium1,medium2 and high concentrations of atorvastatin were both less than 15％.The extraction recoveries were 61.64％-90.29％.The matrix effects were 88.74％-105.62％.Conclusion The established method is rapid,sensitive,accurate,specific and reliable,and suitablefor simultaneous determination of atorvastatin and its active metabolites (ortho-atorvastatin and para-atorvastatin) in human plasma,which meets the needs of clinical therapeutic drug monitoring and pharmacokinetics research.

Determination of Allylestrenol in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry

Determination of Amlodipine Concentration in Human Plasma by LC-MS/MS Method and Bioequivalence Study of Its Tablets

Determination of Levonorgestrel in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry

Determination Of Diethylstilbestrol In Human Plasma With Measurement Uncertainty Estimation By Liquid Chromatography-Tandem Mass Spectrometry

Development of a LC-MS/MS Method for Determination of Plasma Aldosterone and Its Performance Evaluation

An ultra-pressure liquid chromatography-tandem mass spectrometry method for the simultaneous determination of three physalins in rat plasma and its application to pharmacokinetic study of Physalis alkekengi var. franchetii (Chinese lantern) in rats.

Determination of Lovastatin Concentration in Human Plasma by High Performance Liquid Chromatography-Electrospray Mass Spectrometry

Simultaneous determination of atorvastatin and its active metabolites in human plasma by LC-MS/MS

Simultaneous determination of amoxicillin and ambroxol in human plasma by LC-MS/MS: validation and application to pharmacokinetic study

An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆

LC–Tandem-MS Validation for the Quantitative Analysis of Levonorgestrel in Human Plasma

Validated LC-MS/MS method for determination of Alverine and one of its hydroxy metabolites in human plasma along with its application to a bioequivalence study

Determination by HPLC-MS-MS Method and Bioequivalence of Clemastine in Health Volunteers

Determination of Rosuvastatin Concentration in Human Plasma by LC-MS Method

Simultaneous determination of forsythin and its major metabolites in human plasma via liquid chromatography-tandem mass spectrometry

Determination of losartan and its metabolite in human plasma by LC-MS/MS and bioequi valence study of losartan potassium tablets

Measurement of Human Serum Unconjugated Estriol Without Derivatization Using Liquid Chromatography-Tandem Mass Spectrometry Candidate Reference Method and Compared with Two Immunoassays

LC-MS/MS determination of metformin in human plasma

Determination of 2-Hydroxyflutamide in Human Plasma by Liquid Chromatography–tandem Mass Spectrometry (LC–MS/MS): Application to a Bioequivalence Study on Chinese Volunteers

Simultaneous Determination of Paracetamol and Amantadine in Human Plasma and Bioequivalence of Its Preparations in Healthy Volunteers by LC-MS

LC -ESI- MS/MS Determination of Simvastatin in Human Plasma